Zelira Therapeutics Ltd.ASX: ZLD

ZLD Successfully Completes $8.75M Oversubscribed Placement

· Issued by Zelira Therapeutics Ltd.

Filed with ASX · · 3 pages · English

products, generate revenues and progress development of clinically validated medicines. Zelira Therapeutics Ltd (ASX:ZLD, OTCQB:ZLDAF), is pleased to announce it has completed a placement of circa 175,000,000 fully-paid ordinary shares (“New Shares”) at a share price of A$0.05. The Placement will raise approximately A$8.75M before costs (“Placement”). The Placement was strongly supported by new an

Zelira Therapeutics Ltd. on 6ix

Story so far

Earlier from Zelira Therapeutics

Later from Zelira Therapeutics

All Zelira Therapeutics news releases